CFG
MRNA icon

Capstone Financial Group’s Moderna MRNA Stock Holding History

Capstone Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$182K Buy
2,568
+278
+12% +$19.4K 0.14% 82
2020
Q2 		$140K Buy
+2,290
New +$125K 0.12% 85

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Capstone Financial Group's MRNA Position: Q3 2020 in Review

Capstone Financial Group increased its Moderna (MRNA) stake by 12% in Q3 2020, buying an estimated $19.4K and bringing the position to 2,568 shares worth $182K. The position accounts for 0.14% of the portfolio, ranked #82.

Capstone Financial Group first reported a position in MRNA in Q2 2020 and has held it in 2 quarters since. 548 funds tracked by Wall St. Rank hold MRNA as of Q3 2020.

  • Capstone Financial Group held 2,568 shares of Moderna worth $182K as of Q3 2020.
  • Capstone Financial Group bought 278 Moderna shares in Q3 2020, an estimated $19.4K.
  • Moderna made up 0.14% of Capstone Financial Group's portfolio in Q3 2020, its #82 holding.
  • Capstone Financial Group first reported a position in Moderna in Q2 2020 and has held it in 2 quarters since.
  • 548 funds tracked by Wall St. Rank held Moderna as of Q3 2020.

Based on Capstone Financial Group's 13F filing for Q3 2020, filed 9 Oct 2020.